HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transoral laser microsurgery for carcinoma in situ of the glottic larynx. A retrospective follow-up study.

AbstractBACKGROUND:
To investigate long-term results of transoral CO2 laser microresection (TLM) in glottic carcinoma in situ (CIS).
METHODS:
A retrospective study of 34 patients with glottic CIS treated initially with TLM between 1986 and 2004. Median post-operative follow-up time was 62 months.
RESULTS:
Three- and 5-year local control rates were 97 and 93%, respectively. Four patients developed local recurrence (rTis, rTis, rT1, rT4) that could be salvaged by repeated TLM in all cases. Neither adjuvant radiotherapy nor open partial or total laryngectomy was performed. There was no tumour-related death in this series.
CONCLUSION:
TLM can be considered as an effective method in the treatment of glottic CIS not only for the primary therapy, but also in cases of local recurrence.
AuthorsRalph M W Roedel, Hans Christiansen, Roland M Mueller, Christoph Matthias
JournalORL; journal for oto-rhino-laryngology and its related specialties (ORL J Otorhinolaryngol Relat Spec) Vol. 71 Issue 1 Pg. 45-9 ( 2009) ISSN: 1423-0275 [Electronic] Switzerland
PMID19033717 (Publication Type: Journal Article)
CopyrightCopyright 2008 S. Karger AG, Basel.
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma in Situ (surgery)
  • Edema (etiology)
  • Female
  • Follow-Up Studies
  • Glottis (physiopathology, surgery)
  • Humans
  • Laryngeal Diseases (etiology)
  • Laryngeal Neoplasms (surgery)
  • Laser Therapy (adverse effects, methods)
  • Male
  • Microsurgery (adverse effects, methods)
  • Middle Aged
  • Mouth
  • Neoplasm Recurrence, Local (surgery)
  • Neoplasms, Second Primary
  • Postoperative Period
  • Reoperation
  • Retrospective Studies
  • Treatment Outcome
  • Voice
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: